This bill would ban pharmaceutical manufacturers from advertising prescription drugs directly to consumers through any media, including television, radio, print, digital platforms, and social media. The prohibition would apply to all FDA-approved prescription drugs and would take effect 30 days after the bill becomes law. The legislation targets what the pharmaceutical industry calls "direct-to-consumer advertising"—the practice of marketing drugs directly to patients rather than only to doctors. This change would primarily affect drug manufacturers, which currently spend billions annually on consumer-facing drug advertisements, as well as advertising companies and media outlets that profit from such ads. If passed, the United States would join most other developed nations in restricting direct-to-consumer prescription drug advertising.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.